SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-008332
Filing Date
2021-06-16
Accepted
2021-06-16 07:15:41
Documents
3
Period of Report
2021-06-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20210614x8k.htm 8-K 35152
2 EX-99.1 tmb-20210614xex99d1.htm EX-99.1 9919
3 GRAPHIC tmb-20210614xex99d1001.jpg GRAPHIC 3607
  Complete submission text file 0001558370-21-008332.txt   51481
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Filer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39746 | Film No.: 211020482
SIC: 2834 Pharmaceutical Preparations